Integrin beta 3 Binding Protein (Beta3-Endonexin) (ITGB3BP) (N-Term) Peptid
ITGB3BP
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle ITGB3BP Produkte
- ITGB3BP (Integrin beta 3 Binding Protein (Beta3-Endonexin) (ITGB3BP))
- Protein Region
- N-Term
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-ITGB3BP antibody (Catalog #: ARP54999_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- ITGB3BP (Integrin beta 3 Binding Protein (Beta3-Endonexin) (ITGB3BP))
- Synonyme
- CENP-R Peptide, CENPR Peptide, HSU37139 Peptide, NRIF3 Peptide, TAP20 Peptide, 4930471O16Rik Peptide, AU022583 Peptide, integrin subunit beta 3 binding protein Peptide, integrin beta 3 binding protein (beta3-endonexin) Peptide, ITGB3BP Peptide, Itgb3bp Peptide
- Hintergrund
-
ITGB3BP is a transcription coregulator that can have both coactivator and corepressor functions. Isoform 1, but not other isoforms, is involved in the coactivation of nuclear receptors for retinoid X (RXRs) and thyroid hormone (TRs) in a ligand-dependent fashion. ITGB3BP acts as a transcriptional corepressor via its interaction with the NFKB1 NF-kappa-B subunit, possibly by interfering with the transactivation domain of NFKB1. It induces apoptosis in breast cancer cells, but not in other cancer cells, via a caspase-2 mediated pathway that involves mitochondrial membrane permeabilization but does not require other caspases. ITGB3BP may also act as an inhibitor of cyclin A-associated kinase. ITGB3BP may be involved in incorporation of newly synthesized CENPA into centromeres via its interaction with the CENPA-NAC complex.
Alias Symbols: CENP-R, CENPR, HSU37139, NRIF3, TAP20
Protein Interaction Partner: MTA1,ARFIP2,CCNA2,COL4A3BP,DDX24,ESR1,ITGB3,ITGB3BP,ITGB5,MTA1,NFKB1,RECQL5,RXRA,ARFIP2,CCNA2,COL4A3BP,DDX24,ITGB3,ITGB3BP,ITGB5,NFKB1,RECQL5,RELA,RXRA,RXRG,THRA
Protein Size: 177 - Molekulargewicht
- 20 kDa
- Gen-ID
- 23421
- NCBI Accession
- NM_014288, NP_055103
- UniProt
- Q13352
-
Sie sind hier:
